MME and cancer: A unique protumorigenic CAF subset expressing CD10 and GPR77 provides a survival niche for cancer stem cells (CSCs) during chemotherapy for breast and lung cancer [3] and was associated with drug resistance in polyploid giant cancer cells [28].